LEO Pharma

 A–Z catalog of LEO Pharma

A

• Adbry → tralokinumab → Moderate–severe atopic dermatitis → Prefilled syringe/pen: 150 mg; dosing 600 mg loading then 300 mg q2w or q4w

• Adtralza → tralokinumab → Moderate–severe atopic dermatitis → Prefilled syringe: 150 mg; same regimens as above

• Albotop LEO → heparin sodium (topical) → Superficial thrombophlebitis/bruising → Gel: typical heparin 50,000 IU/100 g equivalents (market-dependent)

B

• Burinex → bumetanide → Edema (loop diuretic; legacy markets) → Tabs: 0.5 mg, 1 mg, 2 mg; Injection: 0.25 mg/mL

• Burinex K → bumetanide + potassium chloride → Diuretic with K⁺ supplement (legacy) → Tabs: varies by market

C

• Calcipotriol LEO (Cream) → calcipotriol → Psoriasis (plaque) → 0.005% cream

• Calcipotriol LEO (Ointment) → calcipotriol → Psoriasis → 0.005% ointment

• Calcipotriol LEO (Scalp Solution) → calcipotriol → Scalp psoriasis → 0.005% solution

• Cutivate LEO → fluticasone propionate (topical) → Dermatoses (some legacy LEO markets) → Cream/ointment: 0.05%

D

• Daivobet Gel → calcipotriol + betamethasone dipropionate → Plaque psoriasis (body/scalp) → 50 mcg/g + 0.5 mg/g gel

• Daivobet Ointment → calcipotriol + betamethasone dipropionate → Plaque psoriasis → 50 mcg/g + 0.5 mg/g ointment

• Daivobet Foam → calcipotriol + betamethasone dipropionate → Plaque psoriasis → 50 mcg/g + 0.5 mg/g cutaneous foam

• Daivonex Cream → calcipotriol → Psoriasis → 0.005% cream

• Daivonex Ointment → calcipotriol → Psoriasis → 0.005% ointment

• Daivonex Scalp Solution → calcipotriol → Scalp psoriasis → 0.005% solution

• Dovobet Gel → calcipotriol + betamethasone dipropionate → Psoriasis → 50 mcg/g + 0.5 mg/g gel

• Dovobet Ointment → calcipotriol + betamethasone dipropionate → Psoriasis → 50 mcg/g + 0.5 mg/g ointment

• Dovonex Cream → calcipotriene (US name) → Psoriasis → 0.005% cream

• Dovonex Ointment → calcipotriene → Psoriasis → 0.005% ointment

• Dovonex Scalp Solution → calcipotriene → Scalp psoriasis → 0.005% solution

E

• Enstilar Foam → calcipotriene + betamethasone dipropionate → Plaque psoriasis (body) → 0.005% + 0.064% foam

• Enstilar Foam (Scalp label) → calcipotriene + betamethasone dipropionate → Scalp psoriasis → same strength; labeled for scalp in some markets

F

• Finacea Gel → azelaic acid → Papulopustular rosacea → 15% gel

• Finacea Foam → azelaic acid → Rosacea → 15% foam

• Fucidin Cream → fusidic acid → Impetigo/focal skin infections → 2% cream

• Fucidin Ointment → fusidic acid → Bacterial skin infections → 2% ointment

• Fucidin H Cream → fusidic acid + hydrocortisone acetate → Infected inflammatory dermatoses → 2% + 1% cream

• Fucicort Cream → fusidic acid + betamethasone valerate → Infected eczema/dermatitis → 2% + 0.1% cream

• Fucicort Lipid Cream → fusidic acid + betamethasone valerate (lipid base) → Infected eczema (very dry skin) → 2% + 0.1%

• Fucithalmic Eye Drops → fusidic acid → Bacterial conjunctivitis → 1% (viscous drops)

• Fusidate Sodium Tablets → sodium fusidate → Staphylococcal infections → 250 mg tabs (market-dependent)

• Fusidate Oral Suspension → sodium fusidate → Pediatric staph infections → 250 mg/5 mL (varies)

G

• Gelcutan → heparin (topical) + salicylic acid (var.) → Superficial thrombophlebitis/hematomas → Gel; strengths vary by market

• Group “G” Psoriasis Kit → calcipotriol + betamethasone → Starter pack (some markets) → Gel/foam combos (market-specific)

H

• Heparin LEO Gel → heparin (topical) → Bruising/local thrombophlebitis → e.g., 300–500 IU/g gel (market-dependent)

• Heparin LEO Ointment → heparin (topical) → Same → ointment; strengths vary

• Heparinoid LEO Cream → heparinoid → Superficial thrombosis/bruising → cream (var. strengths)

I

• Innohep 3,500 IU/0.35 mL → tinzaparin sodium → VTE prophylaxis (low body-weight) → Prefilled syringe

• Innohep 4,500 IU/0.45 mL → tinzaparin sodium → VTE prophylaxis → Prefilled syringe

• Innohep 6,500 IU/0.65 mL → tinzaparin sodium → VTE prophylaxis (moderate risk) → Prefilled syringe

• Innohep 8,000 IU/0.8 mL → tinzaparin sodium → VTE treatment/prophylaxis → Prefilled syringe

• Innohep 10,000 IU/1 mL → tinzaparin sodium → VTE treatment → Prefilled syringe

• Innohep 12,000 IU/0.6 mL → tinzaparin sodium → Weight-adjusted dosing packs → Prefilled syringe

• Innohep 14,000 IU/0.7 mL → tinzaparin sodium → VTE treatment (higher weight) → Prefilled syringe

• Innohep 16,000 IU/0.8 mL → tinzaparin sodium → VTE treatment → Prefilled syringe

• Innohep 18,000 IU/0.9 mL → tinzaparin sodium → VTE treatment (very high weight) → Prefilled syringe

• Innohep Multidose Vial → tinzaparin sodium → Inpatient dosing → Vial strengths vary by market

K

• Kyntheum → brodalumab → Moderate–severe plaque psoriasis (EU/UK) → Prefilled syringe: 210 mg

O

• Ointment Base “Lipid-Rich” (LEO Psoriasis) → calcipotriol/betamethasone vehicle → Emollient adjunct (kit) → Ointment vehicle (market kits)

• Oxalate-Free Calcipotriol Kit → calcipotriol → Psoriasis pack → Solution + cream (market-specific)

P

• Picato Gel 0.015% → ingenol mebutate → Actinic keratosis (legacy; some markets withdrawn) → 0.015% gel (field: face/scalp)

• Picato Gel 0.05% → ingenol mebutate → Actinic keratosis (legacy) → 0.05% gel (trunk/extremities)

• Protopic 0.03% Ointment → tacrolimus → Atopic dermatitis (pediatric/maintenance; LEO-marketed in some territories) → 0.03%

• Protopic 0.1% Ointment → tacrolimus → Atopic dermatitis (adult) → 0.1%

• Psorcutan Cream → calcipotriol → Psoriasis → 0.005% cream

• Psorcutan Ointment → calcipotriol → Psoriasis → 0.005% ointment

• Psorcutan Scalp Solution → calcipotriol → Scalp psoriasis → 0.005% solution

S

• Skinoren LEO (market-specific) → azelaic acid → Acne/rosacea (where licensed under LEO) → 20% cream / 15% gel

• Scalp Applicator (Daivobet/Xamiol) → calcipotriol + betamethasone → Scalp psoriasis → 50 mcg/g + 0.5 mg/g solution with nozzle

T

• Taclonex Ointment → calcipotriene + betamethasone dipropionate → Plaque psoriasis → 0.005% + 0.064% ointment

• Taclonex Topical Suspension → calcipotriene + betamethasone dipropionate → Scalp/body psoriasis → 0.005% + 0.064% suspension

• Taclonex Scalp → calcipotriene + betamethasone dipropionate → Scalp psoriasis → same strength; labeled for scalp

• Tinzaparin LEO (Hospital Vial) → tinzaparin sodium → VTE treatment/prophylaxis → Multi-dose vial; strengths vary

• Topical Calcipotriol “LEO Generic Pack” → calcipotriol → Psoriasis → 0.005% (multiple pack sizes)

X

• Xamiol Gel → calcipotriol + betamethasone dipropionate → Scalp psoriasis → 50 mcg/g + 0.5 mg/g gel